Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1561656
PUBLISHER: IMARC | PRODUCT CODE: 1561656
Botulinum Toxin Market Report by Type (Toxin Type A, Toxin Type B), Application (Therapeutics, Aesthetics), End User (Hospitals and Clinics, Dermatology Clinics, Spas and Cosmetic Centers), and Region 2024-2032
PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global botulinum toxin market size reached US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod commonly found in plants, soil, water, and intestinal tracts of animals. It plays a significant role in the management of a wide variety of medical conditions. These conditions include strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, and spastic movement disorders. Moreover, it is utilized in the treatment of various chronic diseases that respond partially to available medical treatments. Nowadays, it is also used for the cosmetic purpose of temporarily reducing frown lines, creases, and wrinkles on the face, chin, neck, and chest.
Botulinum Toxin Market Trends:
A significant rise in the prevalence and diagnosis of chronic and acute diseases represents one of the key factors bolstering the market growth. Botulinum toxin finds extensive applications in the treatment of dermatological conditions, such as overactive smooth muscles, abnormal activity of glands, and hyperhidrosis. Moreover, the rising beauty consciousness among individuals, along with their willingness to undergo reconstructive and cosmetic surgeries, is contributing to market growth. In addition, the emerging trend of cosmetic tourism, in confluence with the increasing influence of social media, rapid urbanization, and inflating per capita income, is influencing the market positively. Apart from this, as the skin becomes more susceptible to wrinkles and sagging with age, the growing geriatric population and the desire to retain young and healthy skin are bolstering the market growth. Furthermore, the development of new potent toxins by combining different serotypes can reduce the total units and overall antigenic dose and improve effectiveness and duration of effect. These advancements are projected to create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global botulinum toxin market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end user.
Breakup by Type:
- Toxin Type A
- Toxin Type B
Breakup by Application:
- Therapeutics
- Aesthetics
Breakup by End User:
- Hospitals and Clinics
- Dermatology Clinics
- Spas and Cosmetic Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Eisai Co. Ltd, Evolus Inc, Galderma SA, HUGEL Inc., Ipsen Group, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics Inc. and Revance Therapeutics Inc.
Key Questions Answered in This Report
- 1. What was the size of the global botulinum toxin market in 2023?
- 2. What is the expected growth rate of the global botulinum toxin market during 2024-2032?
- 3. What has been the impact of COVID-19 on the global botulinum toxin market?
- 4. What are the key factors driving the global botulinum toxin market?
- 5. What is the breakup of the global botulinum toxin market based on type?
- 6. What is the breakup of the global botulinum toxin market based on the application?
- 7. What is the breakup of the global botulinum toxin market based on the end user?
- 8. What are the key regions in the global botulinum toxin market?
- 9. Who are the key players/companies in the global botulinum toxin market?
Product Code: SR112024A4453
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Botulinum Toxin Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Toxin Type A
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Toxin Type B
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Therapeutics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Aesthetics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Dermatology Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Spas and Cosmetic Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 AbbVie Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Eisai Co. Ltd
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Evolus Inc
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Galderma SA
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 HUGEL Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Ipsen Group
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Medytox Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.8 Merz Pharma GmbH & Co. KGaA
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Metabiologics Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Revance Therapeutics Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.1 AbbVie Inc.
Product Code: SR112024A4453
List of Figures
- Figure 1: Global: Botulinum Toxin Market: Major Drivers and Challenges
- Figure 2: Global: Botulinum Toxin Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Botulinum Toxin Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Botulinum Toxin Market: Breakup by Type (in %), 2023
- Figure 5: Global: Botulinum Toxin Market: Breakup by Application (in %), 2023
- Figure 6: Global: Botulinum Toxin Market: Breakup by End User (in %), 2023
- Figure 7: Global: Botulinum Toxin Market: Breakup by Region (in %), 2023
- Figure 8: Global: Botulinum Toxin (Toxin Type A) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Botulinum Toxin (Toxin Type A) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Botulinum Toxin (Toxin Type B) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Botulinum Toxin (Toxin Type B) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Botulinum Toxin (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Botulinum Toxin (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Botulinum Toxin (Aesthetics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Botulinum Toxin (Aesthetics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Botulinum Toxin (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Botulinum Toxin (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Botulinum Toxin (Dermatology Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Botulinum Toxin (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Botulinum Toxin (Spas and Cosmetic Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Botulinum Toxin (Spas and Cosmetic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: North America: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: North America: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: United States: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: United States: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Canada: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Canada: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Asia-Pacific: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Asia-Pacific: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: China: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: China: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Japan: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Japan: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: India: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: India: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: South Korea: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: South Korea: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Australia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Australia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Indonesia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Indonesia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Europe: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Europe: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Germany: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Germany: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: France: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: France: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: United Kingdom: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: United Kingdom: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Italy: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Italy: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Spain: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Spain: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Russia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Russia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Latin America: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Latin America: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Brazil: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Brazil: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Mexico: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Mexico: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Middle East and Africa: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Middle East and Africa: Botulinum Toxin Market: Breakup by Country (in %), 2023
- Figure 70: Middle East and Africa: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Global: Botulinum Toxin Industry: SWOT Analysis
- Figure 72: Global: Botulinum Toxin Industry: Value Chain Analysis
- Figure 73: Global: Botulinum Toxin Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Botulinum Toxin Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Botulinum Toxin Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Botulinum Toxin Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 4: Global: Botulinum Toxin Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 5: Global: Botulinum Toxin Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Botulinum Toxin Market: Competitive Structure
- Table 7: Global: Botulinum Toxin Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.